Series Unknown Funded Startups in France
Across the 50 most recent “Series Unknown” rounds in France, the largest disclosed amount is Electra’s $333M (2025-07-24).
Across the 50 most recent “Series Unknown” rounds in France, the largest disclosed amount is Electra’s $333M (2025-07-24). That figure dwarfs the rest of the disclosed rounds, with the next-largest disclosed entries including Sequans Communications ($195M on 2025-06-23) and Knave ($115M on 2025-06-05). The low end includes very small disclosed financings such as Lprint ($100K on 2025-05-16) and Dr. Jonquille & Mr. Ail ($100K on 2025-05-15), alongside multiple “undisclosed” rounds (6 entries total).
The list is also geographically and temporally concentrated: Ile-de-France shows up repeatedly, including Paris-area addresses for companies like Electra (2025-07-24), Flowdesk (2025-06-24, $100M), and GATEWATCHER (2025-06-26, $29M). Date-wise, rounds cluster tightly between April 1, 2025 (AQEMIA, $7M) and August 28, 2025 (A.M.A Selections, $690K), with a dense run from mid-June through late July. Sector-wise, Biotechnology is the dominant theme, appearing in 13 of the 50 entries (e.g., Osivax at $20M on 2025-08-26; Innate Pharma at $17M on 2025-04-24).
Most recent rounds
50 shownRelated listings
Frequently asked
What stands out as the biggest disclosed “Series Unknown” round in France here, and how separated is it from the rest?
Electra’s $333M (2025-07-24) is the largest disclosed amount in the visible rows and sits well above other big disclosed rounds such as Sequans Communications’ $195M (2025-06-23) and Knave’s $115M (2025-06-05).
How common are undisclosed amounts, and do any disclosed rounds sit at the floor?
There are 6 “undisclosed” entries in the 50-row set. Among disclosed rounds, the smallest disclosed amount is $100K, showing up twice: Lprint ($100K on 2025-05-16) and Dr. Jonquille & Mr. Ail ($100K on 2025-05-15).
Where is the concentration geographically, based on recurring city/region patterns?
Ile-de-France dominates the address list, with multiple rounds tied to Paris-area locations such as Electra ($333M, 2025-07-24), Flowdesk ($100M, 2025-06-24), and GATEWATCHER ($29M, 2025-06-26). Outside the region, other examples include Lyon-based Osivax ($20M, 2025-08-26) and Bordeaux-based TreeFrog Therapeutics ($34M, 2025-05-27).
Which sectors appear most often among these “Series Unknown” rounds?
Biotechnology is the clear leader at 13 of 50 entries, including Osivax ($20M, 2025-08-26), MaaT Pharma ($44M, 2025-07-28), and Innate Pharma ($17M, 2025-04-24). Other sectors appear but at lower counts (no other sector reaches the same frequency in this visible slice).
Are there any sharp outliers in timing or size within the April–August 2025 window?
Timing is bounded between 2025-04-01 (AQEMIA, $7M) and 2025-08-28 (A.M.A Selections, $690K), with particularly heavy activity between mid-June and late July. Size-wise, Electra’s $333M (2025-07-24) is the standout outlier against the next-largest disclosed amounts like Sequans Communications’ $195M (2025-06-23).
What’s the stage mix signal in practice—does “Series Unknown” obscure variety or cluster around specific kinds of rounds?
All 50 rows are labeled “Series Unknown,” but disclosed amounts span from $100K (Lprint and Dr. Jonquille & Mr. Ail in May 2025) up to $333M (Electra in July 2025), indicating wide dispersion rather than a single dominant disclosed check size. The presence of multiple undisclosed entries (6 total) further suggests that disclosed magnitude alone may not fully explain round behavior across this set.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.